1.Application of RFID Medicine Logistic Box in the Inpatient Pharmacy of Our Hospital
Zheng REN ; Qian LI ; Zhongsheng GU ; Ling MENG
China Pharmacy 2017;28(19):2733-2736
OBJECTIVE:To achieve the drug intelligent supervision in transportation within hospital and storage process,and promote quality safety of drugs. METHODS:The function and operation of Radio frequency identification(RFID)medicine logis-tic box was introduced,its application in one year in inpatient pharmacy of our hospital since Sept. 2013 was summarized,and its application effect and deficiency were analyzed. RESULTS:RFID medicine logistic box showed heat preservation and locking func-tions,which can be used for the cold-chain medicine and lock packing transportation for the ward. It can achieve information bind-ing after connecting with corresponding platform,record real-time record temperature,logistic box opening and closing information and data,as well as a variety of ways to alarm by SMS and mail,etc. However,failed login server and unpacking caused by unsta-ble wireless signals were found when applying the box,also drug damage and other defects were caused by unreasonable box struc-ture. And the daily average incidence dropped from the initial period (Nov. 2013) 11.9 times (cases) to the late period (Sept. 2014) 3.3 times (cases) after continuous improvement. CONCLUSIONS:Applying of medicine logistic box can strengthen cold-chain transport integrity and regulatory information in our hospital,ensure the safety of drug transport and query traceability of information.
2.Effect of Jiangsu Pharmaceutical Management Quality Control Center on Promoting the Rational Use of Antibacterial Agents in Hospitals
Zheng REN ; Qian LI ; Zhongsheng GU ; Ling MENG
China Pharmacy 2017;28(34):4771-4775
OBJECTIVE:To describe the effect of Jiangsu Pharmaceutical Management Quality Control Center(JPMQCC)on promoting the rational use of antibacterial agents in hospitals. METHODS:Measures in promoting the rational use of antibacterial agents taken by JPMQCC were introduced. Effect of quality control center on promoting the rational use of antibacterial agents was analyzed by collecting data(such as antibacterial prescription proportion,inpatients'use rate of antibacterial agents)about the clini-cal use of antibacterial agents during Jan. 2014-Jan. 2017 in"Jiangsu Pharmaceutical Management Quality Control Network Report-ing System"established by JPMQCC. RESULTS:Measures implemented and developed by quality center included strictly imple-menting classification management and filing system of antibacterial agents,and carrying out basic information survey for applying antibacterial agents,etc. Applying data of antibacterial agents in totally 65 hospitals were collected. Analysis results showed,com-pared with Jan. 2014,antibacterial prescription proportion for outpatient of sample hospitals in Jan. 2017 was decreased from 18.37% to 14.63%,and antibacterial prescription proportion for emergency was increased from 34.94% to 37.92%. Inpatients'use rate of antibacterial agents was decreased from 56.11%to 51.28%,and its intensity was decreased from 49.74 to 44.13. The preven-tive use rate for thyroid,breast and hernia surgery was decreased from 35.27% to 8.88%,and in interventional surgery diagnosis, it was decreased from 12.55% to 2.46%. Pathogenic detection rate of inpatients was increased from 48.44% to 54.60%. CONCLU-SIONS:The quality control management in JPMQCC for more than 3 years has promoted the rational use of antibacterial agents of 65 hospitals in Jiangsu province.
3.Selection of surgical methods for different sites of symptomatic Rathke's cleft cyst and clinical efficacies of these patients
Xinqing DENG ; Zhongsheng BI ; Zhenghao FU ; Junbin CAI ; Jiankan LU ; Deliu LIN ; Youming GU ; Xingke LI ; Mi GUO ; Guili FENG
Chinese Journal of Neuromedicine 2021;20(4):384-388
Objective:To explore the selection of surgical methods for different sites of symptomatic Rathke's cleft cyst (RCC) and the clinical efficacies of these patients.Methods:Forty-seven patients with symptomatic RCC, admitted to our hospital from January 2016 to December 2019, were chosen in our study; 21 patients with intrasellar symptomatic RCC accepted surgery via unilateral nasal approach at the right side, 19 patients with intra-suprasellar symptomatic RCC accepted surgery via bilateral nasal approach, 3 patients with suprasellar symptomatic RCC accepted endonasal transsphenoidal surgery under endoscope, and 4 patients with suprasellar symptomatic RCC accepted craniotomy via pterion approach. The clinical efficacies and complications of patients accepted different surgical methods were compared. All patients were followed up for 3-36 months to observe the recurrence.Results:The postoperative symptoms of the patients were effectively improved, including headache relief ratio of 27/31, vision loss improvement ratio of 5/5, high prolactin relief ratio of 11/13, pituitary function improvement ratio of 9/18. Complications occurred in 6 patients, presenting as diabetes insipidus. Four patients recurred during follow-up.Conclusion:Intrasellar and intra-suprasellar symptomatic RCC accepted surgery via endoscopic transnasal transsphenoidal approach are safe and effective; selection of surgical methods for suprasellar symptomatic RCC should be determined according to the sizes and growth directions of cysts.
4.Interpretation of guideline for breast cancer screening in Chinese women
Yubei HUANG ; Zhongsheng TONG ; Kexin CHEN ; Ying WANG ; Peifang LIU ; Lin GU ; Juntian LIU ; Jinpu YU ; Fengju SONG ; Wenhua ZHAO ; Yehui SHI ; Hui LI ; Huaiyuan XIAO ; Xishan HAO
Chinese Journal of Clinical Oncology 2019;46(9):433-441
Breast cancer is the most common cancer for Chinese women. Early screening is the best way to improve the rates of early diagnosis and early treatment of breast cancer. The peak ages of breast cancer in Chinese women are obviously different from those in the European and American countries. It is imperative to develop a guideline for breast cancer screening that is suitable for Chinese women. Based on the analysis and summary of breast cancer screening data in China, and the latest guidelines and consensus on breast cancer screening in Europe, the United States and East Asia, China Anti-Cancer Association and National Clinical Research Center for Cancer (Tianjin Medical University Cancer Institute and Hospital) has developed a population-based guideline for breast cancer screening in Chinese women. This guideline has provided detailed recommendations on the screening starting age, screening modalities, and screening interval in Chinese women with average risk and high risk of breast cancer, respectively. This article aims to interpret the above guideline, providing references for professionals in breast cancer screening.